Olatorepatide — catalyst calendar
Upcoming
| Date | Event | Company | Drug | Official source & verification |
|---|---|---|---|---|
| 2026-11-13 in 5mo
ESTIMATED |
READOUT
Study of Olatorepatide in Adult Participants Living With Overweight or Obesity i
Phase 2 · Overweight or Obesity |
REGN REGENERON PHARMACEUTICALS, I | Olatorepatide |
ClinicalTrials.gov ↗
✓ Source-checked 2026-06-22
Sponsor-projected date — can change
|